Search
forResearch 10 of 1000+
- A Natural Inhibitor, 1′S-1′-Acetoxychavicol Acetate, Against Testosterone-Induced Alopecia via NADPH Oxidase Regulation
- THE ROLE Of 5αR AND α1AR INHIBITORS IN MANAGEMENT OF BPH
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Letter to the Editor: A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Healthcare System
- Hair Growth-Promoting Effects of a Multi-Targeted Cosmetic Formulation Containing PYGL, DP2, and 15-PGDH Inhibitors Developed Using AI-Based DeepZema® in Androgenetic Alopecia: A 24-Week Randomized Controlled Trial
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: A possible androgenic bone protective effects induced by exemestane
- Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonist
- A Comprehensive Review on Skin Pigmentation-Types, Causes, and Treatment
- A clinician’s guide to pediatric and adolescent alopecia areata treatments
Community 10 of 58
- Is there any role for topical DHT antagonists, or does a 5-AR inhibitor remove the need for them as therapy
- Why does this industry still revolve around 5-AR inhibitors?
- BREAKTHROUGH: I’m a radiochemist and discovered a radioactive isotope scalp serum that OUTPERFORMS Minoxidil and 5-AR inhibitors! (Lab Data Inside)
- 1 year 5-ar. Blood test results
- Stopped topical Minox and Fin for 2 years, started again and gained my old status back
- Question about clascoterone acne cream
- Why are there no FDA approved NSAA's yet?
- Breaking hair loss news! GT20029 is a resounding success!
- bro where tf is GT20029, Q1 2024 is over already
- Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China
Learn
— no results
Try a deeper search in learn →